Waun Ki Hong, MD
Head, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Dr. Waun Ki Hong is a Division Head and Professor at the University of Texas M. D. Anderson Cancer Center. He is an American Cancer Society Professor and a Samsung Distingushed University Chair in Cancer Medicine. Dr. Hong received his bachelor of science and medical degree at the Yon Sei University College of Engineering Science in Seoul, Korea. He went on to do his residency at the Boston Veterans Affairs Medical Center and became a Medical Oncology Fellow at the Memorial Sloan-Kettering Cancer Center in New York City. He joined M. D. Anderson in 1984 as chief of the Section of Head and Neck Medical Oncology, and became chair of the Department of Thoracic/Head and Neck Medical Oncology in 1993.
Dr. Hong's focus has been on the treatment and prevention of head and neck cancer, and lung cancer. He is one of the pioneers of cancer chemoprevention. For one, he demonstrated that high-dose retinoic acid can reverse oral premalignant lesions and prevent the development of second primary tumors. He has also led the charge in advancing personalized lung cancer treatment. His Biomarker-based Approaches of Targeted Therapy for Lung Cancer Elimination project (BATTLE) assigns patients to treatments to which they are most likely to respond based on analyses of their tumor samples.
He has authored more than 660 scientific publications, and edited 11 books, including the 8th edition of the reference book Holland-Frei Cancer Medicine. As Head of the Division of Cancer Medicine, Dr. Hong oversees more than 300 faculty and 13 clinical centers. Dr. Hong was AACR president in 2001 and 2002. His many honors for outstanding achievements in clinical research and patient care include: the AACR's Joseph H. Burchenal and the Rosenthal Foundation Awards; and the American Society of Clinical Oncology's most prestigious award, the David A. Karnofsky Award.